Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
Chinami Masuda(Chugai Pharma (United States)), Kaname Yamamoto
Cited by 38
Related Papers
PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model
|Clinical & Experimental Metastasis|2024|5